Guardant Health (GH) Stock Statistics & Valuation Metrics

Guardant Health has a market cap or net worth of $4.95B. The enterprise value is $5.78B.

Guardant Health has 123,888,050 shares outstanding. The number of shares has decreased by -2.65% in one year.

Guardant Health’s return on equity (ROE) is 3.12 and return on invested capital (ROIC) is -35.31%.

The current PE Ratio of Guardant Health is -8.59. Guardant Health’s PEG ratio is -2.60.

In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.

In the last 12 months, operating cash flow was -272.26M and capital expenditures -32.61M, giving a free cash flow of -304.87M billion.

Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―

Guardant Health upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Guardant Health as a current ratio of 4.68, with Debt / Equity ratio of -520.91%

In the past 12 months, Guardant Health has paid 1.28M in taxes.

Guardant Health EV to EBITDA ratio is -11.69, with an EV/FCF ratio of -16.59.

Guardant Health has $698.57M in cash and marketable securities with $1.31B in debt, giving a net cash position of $607.81M billion.

Gross margin is 61.34%, with operating margin of -60.02%, and net profit margin of -59.05%.

The average price target for Guardant Health is $60.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy